ROBERT HERSHBERG
CIK 1274139 · President and CEO · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.35M
Companies
7
Total Filings
65
Lifetime Open-Market Net
-$4.00M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATAI | Director | — | $3.92 | — | $0 | 2 | 2026-06-08 |
| ADPT | Director | 62,347 | $17.60 | $1.10M | -$2.67M | 22 | 2026-03-06 |
| HilleVax, Inc. (HLVX) Delisted | President and CEO | 0 | $2.09 | $0 | -$221.8K | 4 | 2025-09-17 |
| RXRX | Director | 73,732 | $3.15 | $232.3K | $0 | 9 | 2025-06-23 |
| FATE | Director | 10,659 | $2.06 | $22.0K | -$15.3K | 5 | 2023-06-07 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | — | $5.87 | — | $0 | 3 | 2022-06-13 |
| NanoString Technologies Inc (NSTG) Delisted | Director | 10,716 | $0.11 | $1.1K | -$1.09M | 20 | 2022-04-18 |
Recent Filings · Page 2 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-06 | ADPT | Grant (A) | +31,328 | $0 | EDGAR |
| 2024-02-12 | HilleVax, Inc. (HLVX) Delisted | Mixed | +162,605 | -$173.2K | EDGAR |
| 2023-06-21 | RXRX | Grant (A) | +12,612 | $0 | EDGAR |
| 2023-06-07 | FATE | Grant (A) | — | $0 | EDGAR |
| 2023-03-08 | ADPT | Grant (A) | +14,775 | $0 | EDGAR |
| 2023-02-03 | ADPT | Exer (M) | +53,000 | $23.9K | EDGAR |
| 2023-02-03 | HilleVax, Inc. (HLVX) Delisted | Grant (A) | +187,966 | $0 | EDGAR |
| 2022-06-16 | RXRX | Grant (A) | +18,145 | $0 | EDGAR |
| 2022-06-13 | FATE | Grant (A) | +8,650 | $0 | EDGAR |
| 2022-06-13 | ARS Pharmaceuticals, Inc. (SBTX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.